Stephanie Parsons

Targeted inhibition of p38 MAPK promotes hypertrophic cardiomyopathy through upregulation of calcineurin-NFAT signaling.

Timothy E Hewett, T. Hewett, J. Molkentin, 2003, The Journal of clinical investigation.